Results 131 to 140 of about 76,191 (305)
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study. [PDF]
, 2017 Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT). However, little is known about the impact of prior IFI on survival.
Aljurf, M +26 more
core
Exploring Cancer‐Associated Fibroblasts in OSCC and OPMDs: Microenvironment Insights. Scoping Review
Oral Diseases, EarlyView.ABSTRACT Introduction The tumor microenvironment (TME) plays a crucial role in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs). Despite progress, the mechanisms behind the TME‐epithelial cell interaction remain unclear.
Samuele Sutera +2 more
wiley +1 more source
Janus kinase inhibition in the treatment and prevention of graft-versus-host disease
Frontiers in ImmunologyGraft-versus-host disease (GVHD) is a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). For many years, corticosteroids have been the mainstay treatment for GVHD, but cases of steroid-refractory
Elisa De Togni +2 more
doaj +1 more source
Transplant Infectious Disease, EarlyView.Posttransplant Mycobacterium abscessus infection occurred in 53% of patients with pretransplant infection. While pretransplant infection itself was not associated with impaired survival, both failure to achieve microbiological eradication before transplant and persistent posttransplant disease were linked to increased mortality.
Roni Bitterman +17 more
wiley +1 more source
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation. [PDF]
, 2011 Despite its common use in nonmyeloablative preparative regimens, the pharmacokinetics of fludarabine are poorly characterized in hematopoietic cell transplantation (HCT) recipients and exposure-response relationships remain undefined.
Brunstein, CG +9 more
core +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 4, Page 513-515, April 2025.
Alba Calleja Algarra +7 more
wiley +1 more source
Transplant Infectious Disease, EarlyView.Prophylactic oral vancomycin was associated with reduced Clostridium difficile infection in allogeneic stem cell transplant patients. No differences in hospital‐acquired infections, mortality, GVHD, or rehospitalization were observed. It is a low‐cost, effective preventative strategy, though further prospective studies are needed to confirm safety and ...
Brendon Fusco +8 more
wiley +1 more source
Transplant Infectious Disease, EarlyView.Because the relationship between the gut microbiota and liver transplant outcomes is not well described, it is possible that there are, as yet, unrecognized negative impacts of antibiotic exposures on key liver transplant‐related outcomes. We observed a negative association between antibiotic exposures, particularly those with an anaerobic spectrum of ...
Olivia C. Smibert +11 more
wiley +1 more source
Transplant Infectious Disease, EarlyView.ABSTRACT Background Broad‐spectrum antibiotics are standard for febrile neutropenia (FN) in allogeneic hematopoietic stem cell transplantation (HSCT) but may disrupt gut microbiota, increasing the risk of graft‐versus‐host disease (GVHD). However, current evidence on the effects of anaerobic versus limited anaerobic antibiotic coverage on GVHD‐related
Hiroshi Ito +5 more
wiley +1 more source
A combined biomarker and clinical panel for chronic graft versus host disease diagnosis. [PDF]
, 2017 Whilst many chronic graft versus host disease (cGVHD) biomarkers have been previously reported, few have been verified in an independent cGVHD cohort. We aimed to verify the diagnostic accuracy of previously reported markers of cGVHD in a multi-centre ...
Flowers, Mary Ed +9 more
core